Herbas VPB

Print
EN | LT
LT - ARGININE DEIMINASE WITH REDUCED CROSS-REACTIVITY TOWARD ADI - PEG 20 ANTIBODIES FOR CANCER TREATMENT
EN - ARGININE DEIMINASE WITH REDUCED CROSS-REACTIVITY TOWARD ADI - PEG 20 ANTIBODIES FOR CANCER TREATMENT

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 38/50 (2006.01)
A61K 47/60 (2017.08)
A61K 47/60 (2017.01)
A61K 38/50 (2013.01)
A61P 35/00 (2006.01)
A61K 45/06 (2013.01)
A61K 45/06 (2006.01)
C12N 9/78 (2013.01)
C12N 9/78 (2006.01)
C12Y 305/03006 (2013.01)
A61P 35/02 (2006.01)
A61P 35/00 (2018.01)
A61P 35/02 (2018.01)
European patent
(11) Number of the document 3193913
(13) Kind of document T
(96) European patent application number 15842576.9
Date of filing the European patent application 2015-09-16
(97) Date of publication of the European application 2017-07-26
(45) Date of publication and mention of the grant of the patent 2022-05-11
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2015/050354
Date 2015-09-16
PCT application publication
(87) Number WO 2016/044376
Date 2016-03-24
Priority applications
(30) Number Date Country code
201462051182 P 2014-09-16 US
Inventors
(72)
SHOWALTER, Richard , US
ALMASSY, Robert , US
THOMSON, James A. , US
SISSON, Wes , US
SHIA, Wei-Jong , US
CHEN, Li-Chang , US
LEE, Yang , US
Grantee
(73) Polaris Group , P.O. Box 309 Ugland House, Grand Cayman, KY1-1104, KY
Title
(54) ARGININE DEIMINASE WITH REDUCED CROSS-REACTIVITY TOWARD ADI - PEG 20 ANTIBODIES FOR CANCER TREATMENT
  ARGININE DEIMINASE WITH REDUCED CROSS-REACTIVITY TOWARD ADI - PEG 20 ANTIBODIES FOR CANCER TREATMENT